Är ett framtida vaccin mot Alzheimers sjukdom möjligt?

Är ett framtida vaccin mot Alzheimers sjukdom möjligt?

Alzheimers sjukdom är en smygande neurodegenerativ demenssjukdom som främst drabbar äldre och som karakteriseras av uppkomsten av amyloidplack och neurofibriller i hjärnan. De vanligaste symptomen är demens, kognitiva problem, inbillningar och aggressivitet. Alzheimer förekommer i två olika former,...

Full description

Bibliographic Details
Main Author:	Boqvist, Natalie
Format:	Others
Language:	Swedish
Published:	Uppsala universitet, Institutionen för biologisk grundutbildning 2014
Subjects:	Alzheimer´s disease dementia active vaccine passive vaccine cure future treatment beta-amyloid amyloid plaques neurofibrillary tangles tau AN-1792 CAD106 Bapineuzumab Solanezumab Alzheimers sjukdom demens aktivt vaccin passivt vaccin botemedel framtida behandlingsmetod amyloidplack neurofibriller
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-226441

Similar Items

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
by: Francesca Mantile, et al.
Published: (2020-11-01)

Hur effektiv och säker är behandling med monoklonala antikroppar vid Alzheimers sjukdom?
by: Skoglund, Jasmine
Published: (2019)

Research Progress in the Pathogenesis of Alzheimer's Disease
by: Yi-Gang Chen
Published: (2018-01-01)

Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies
by: Qiuchen Zheng, et al.
Published: (2019-06-01)

The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease
by: Kunie Ando, et al.
Published: (2020-06-01)

Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
by: Tsuyoshi Nakai, et al.
Published: (2021-05-01)

Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
by: Kohyama K, et al.
Published: (2015-01-01)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
by: Selma M. Soyal, et al.
Published: (2020-08-01)

Etude de la dynamique de tau dans le compartiment synaptique dans un contexte physiologique et pathologique exemple de la maladie d'Alzheimer
by: Frandemiche, Marie-Lise
Published: (2013)

The neuroprotective effect of immune serum of adeno-associated virus vaccine containing Aβ1-15 gene on amyloid toxicity
by: Ling-Yun Liu, et al.
Published: (2013-01-01)

Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
by: Sarah Houben, et al.
Published: (2020-07-01)

Genetic and non-genetic factors responsible for mitochondrial failure and Alzheimer’s disease
by: Gao Kuo, et al.
Published: (2014-01-01)

Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials
by: Abdelrahman Ibrahim Abushouk, et al.
Published: (2017-04-01)

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
by: Jie Liu, et al.
Published: (2019-08-01)

In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy
by: Maria Calvo-Rodriguez, et al.
Published: (2019-11-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)

Active immunization trial in Aβ42-injected P301L tau transgenic mice
by: Luka Kulic, et al.
Published: (2006-04-01)

Inhibiteurs et modèles moléculaires de fibres amyloïdes ° et tau impliquées dans la maladie d'Alzheimer : conception, synthèse et caractérisation
by: Dufour, Emilie
Published: (2013)

Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
by: Vanessa de Jesus R. de Paula, et al.

New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease
by: Nicolas Sergeant, et al.
Published: (2019-09-01)

Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes
by: M.A Kurt, et al.
Published: (2003-10-01)

The role of mutated amyloid beta 1⁃42 stimulating dendritic cells in a PDAPP transgenic mouse
by: Jia⁃lin LI, et al.
Published: (2012-06-01)

Periodontitis and Alzheimer’s Disease: A Possible Comorbidity between Oral Chronic Inflammatory Condition and Neuroinflammation
by: Francisco B. Teixeira, et al.
Published: (2017-10-01)

The neuropathological diagnosis of Alzheimer’s disease
by: Michael A. DeTure, et al.
Published: (2019-08-01)

Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
by: Hui‐Fu Wang, et al.
Published: (2020-01-01)

Peptides as Potential Therapeutics for Alzheimer’s Disease
by: Samo Ribarič
Published: (2018-01-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
by: Marcella Catania, et al.
Published: (2019-11-01)

Yeast-Based Aβ1-15 Vaccine Elicits Strong Immunogenicity and Attenuates Neuropathology and Cognitive Deficits in Alzheimer’s Disease Transgenic Mice
by: Dong-qun Liu, et al.
Published: (2020-07-01)

Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology
by: Roger N. Rosenberg, et al.
Published: (2018-11-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
by: Juanjuan Zhao, et al.
Published: (2017-07-01)

Advances and considerations in AD tau-targeted immunotherapy
by: Alice Bittar, et al.
Published: (2020-02-01)

Emerging Signal Regulating Potential of Genistein Against Alzheimer’s Disease: A Promising Molecule of Interest
by: Md. Sahab Uddin, et al.
Published: (2019-09-01)

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
by: Zenghui Wei, et al.
Published: (2021-07-01)

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
by: Woo Shik Shin, et al.
Published: (2019-10-01)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2020-03-01)

Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis
by: Molly E. V. Swanson, et al.
Published: (2020-10-01)

Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2019-12-01)

Cannot write session to /tmp/vufind_sessions/sess_jr37ptchp82dnlvob8l7keqgnu